To view the PDF file, sign up for a MySharenet subscription.
Back to SENS
LIFEHC:  1,181   +8 (+0.68%)  19/02/2026 19:14

LIFE HEALTHCARE GROUP HOLDINGS LIMITED - Report on proceedings at the annual general meeting and changes to the board

Release Date: 19/02/2026 15:57
Code(s): LHC LHC02 LHC06 LHC05 LHC03 LHC04     PDF:  
Wrap Text
Report on proceedings at the annual general meeting and changes to the board

LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
JSE and A2X share code: LHC
("Life Healthcare" or "the Company" or the "Group")

LIFE HEALTHCARE FUNDING LIMITED
(Incorporated in the Republic of South Africa with limited liability)
Registration number: 2016/273566/06
LEI: 3789SJPQJZF8ZYXTZ394
Bond company code: LHFI
("Life Healthcare Funding")

REPORT ON PROCEEDINGS AT THE ANNUAL GENERAL MEETING AND CHANGES TO THE BOARD

At the 21st annual general meeting ("AGM") of the shareholders of Life Healthcare held today, 19 February 2026,
all the ordinary and special resolutions proposed at the meeting were approved by the requisite majority of votes.
In this regard, Life Healthcare confirms the voting statistics from the AGM as follows:

 Resolutions                                   Votes cast are           Number of        Shares voted     Shares
                                               disclosed as a           shares voted     disclosed as     abstained
                                               percentage in                             a percentage     disclosed as
                                               relation to the total                     in relation to   a percentage
                                               number of shares                          the total        in relation to
                                               voted at the meeting                      issued           the total
                                                                                         shares*          issued
                                               For           Against                                      shares*

 ORDINARY RESOLUTION NUMBER 1.1:                 99,50%        0,50%     1 170 546 675      79,77%           0,01%
 Re-appointment of Deloitte as the
 independent external auditor
 ORDINARY RESOLUTION NUMBER 1.2:                 99,50%        0,50%     1 170 546 674      79,77%           0,01%
 Appoint Thegarajan Marriday as the
 individual designated auditor
 ORDINARY RESOLUTION NUMBER 2.1:                 95,29%        4,71%     1 170 546 674      79,77%           0,01%
 Re-election of director – V Litlhakanyane
 ORDINARY RESOLUTION NUMBER 2.2:                 96,12%        3,88%     1 170 546 674      79,77%           0,01%
 Re-election of director – C Henry
 ORDINARY RESOLUTION NUMBER 2.3:                 94,97%        5,03%     1 170 546 674      79,77%           0,01%
 Re-election of director – P Moeketsi
 ORDINARY RESOLUTION NUMBER 3.1:                 95,66%        4,34%     1 170 546 674      79,77%           0,01%
 Re-election of Audit and Risk Committee
 member – F Tonelli
 ORDINARY RESOLUTION NUMBER 3.2:                 96,12%        3,88%     1 170 546 674      79,77%           0,01%
 Re-election of Audit and Risk Committee
 member – C Henry (subject to re-election
 as per 2.2)
 ORDINARY RESOLUTION NUMBER 3.3:                 94,21%        5,79%     1 170 546 674      79,77%           0,01%
 Re-election of Audit and Risk Committee
 member – A Mothupi-Palmstierna
 ORDINARY RESOLUTION NUMBER 3.4:                 94,97%        5,03%     1 170 546 674      79,77%           0,01%
 Re-election of Audit and Risk Committee
 member – P Moeketsi (subject to re-
 election as per 2.3)
 ORDINARY RESOLUTION NUMBER 4.1:                 94,80%        5,20%     1 170 551 015      79,77%           0,00%
 Re-election of Social, Ethics and
 Transformation Committee member – M
 Sello
 ORDINARY RESOLUTION NUMBER 4.2:                 96,12%        3,88%     1 170 546 674      79,77%           0,01%
 Re-election of Social, Ethics and
 Transformation Committee member –
 C Henry (subject to re-election as per 2.2)
 ORDINARY RESOLUTION NUMBER 4.3:                 94,33%        5,67%     1 170 546 674      79,77%           0,01%
 Re-election of Social, Ethics and
 Transformation Committee member –
 A Mothupi-Palmstierna
 ORDINARY RESOLUTION NUMBER 4.4:                 95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Election of Social, Ethics and
 Transformation Committee member –
 F Abdullah
 ORDINARY RESOLUTION NUMBER 4.5:                 95,39%        4,61%     1 170 551 014      79,77%           0,00%
 Re-election of Social, Ethics and
 Transformation Committee member –
 P Wharton-Hood
 ORDINARY RESOLUTION NUMBER 5:                   99,62%        0,38%     1 170 546 675      79,77%           0,01%
 Authority to sign documents to give
 effect to resolutions
 ORDINARY RESOLUTION NUMBER 6.1:                 74,64%        25,36%    1 170 519 097      79,77%           0,01%
 Non-binding advisory vote on the
 Remuneration Policy
 ORDINARY RESOLUTION NUMBER 6.2:                 74,64%        25,36%    1 170 519 097      79,77%           0,01%
 Non-binding advisory vote on the
 Remuneration Implementation Report
 SPECIAL RESOLUTION NUMBER 1.1:                  95,50%        4,50%     1 170 546 674      79,77%           0,01%
 Approval of the Chairman's board fees
 and the Board members' fees
 SPECIAL RESOLUTION NUMBER 1.2:                  95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Approval of the Lead Independent
 director's fees
 SPECIAL RESOLUTION NUMBER 1.3:                  95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Approval of the Audit and Risk
 Committee Chairman's fees and the
 Committee members' fees
 SPECIAL RESOLUTION NUMBER 1.4:                  95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Approval of the Human Resources and
 Remuneration Committee Chairman's
 fees and the Committee members' fees
 SPECIAL RESOLUTION NUMBER 1.5:                  95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Approval of the Nominations and
 Governance Committee Chairman's fees
 and the Committee members' fees
 SPECIAL RESOLUTION NUMBER 1.6:                  95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Approval of the Investment Committee
 Chairman's fees and the Committee
 members' fees
 SPECIAL RESOLUTION NUMBER 1.7:                  95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Approval of the Clinical Committee
 Chairman's fees and the Committee
 members' fees
 SPECIAL RESOLUTION NUMBER 1.8:                  95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Approval of the Social, Ethics and
 Transformation Committee Chairman's
 fees and the Committee members' fees
 SPECIAL RESOLUTION NUMBER 1.9:                  95,40%        4,60%     1 170 546 674      79,77%           0,01%
 Approval of the ad hoc material Board
 and Committee fees per meeting
 SPECIAL RESOLUTION NUMBER 2:                    95,79%        4,21%     1 170 546 674      79,77%           0,01%
 General authority to provide financial
 assistance in terms of sections 44 and 45
 of the Companies Act
 SPECIAL RESOLUTION NUMBER 3:                    99,99%        0,01%     1 170 457 389      79,77%           0,01%
 General authority to repurchase
 Company shares

*Total issued shares is 1 467 349 162

Shareholders and noteholders are advised that as a result of more than 25% of the votes cast against ordinary
resolutions number 6.1 and 6.2, and in accordance with the King IV Report on Corporate Governance for South
Africa, 2016 and paragraph 3.84(j) of the JSE Limited ("JSE") Listings Requirements, the Company will invite
dissenting shareholders who voted against ordinary resolutions number 6.1 and 6.2 to engage with the Company
regarding their views on Life Healthcare's remuneration policy. A date and time for this engagement will be
communicated to shareholders in due course. In the interim, shareholders may forward their concerns/ questions
regarding Life Healthcare's remuneration policy to the Company Secretary via email at
CompanySecretary@life.co.za.

The special resolution/s will, where necessary, be lodged for registration with the Companies and Intellectual
Property Commission in due course.

Changes to the board of directors
Shareholders and noteholders are further advised that in accordance with paragraph 6.71 of the JSE Listings
Requirements, Prof Marian Jacobs and Dr Jeanne Bolger will be retiring and stepping down from the Life Healthcare
Board with effect from the date of the AGM. While on the Company's Board, Marian served on the Clinical
Committee as the Chairman, Social, Ethics and Governance Committee and the Risk, Compliance and IT Governance
Committee, which later dissolved into the Audit and Risk Committee. Jeanne served on the Clinical and Investment
Committees. The Board wishes to thank them both for their invaluable contributions over the years.
The report of the Social, Ethics and Transformation Committee of the Company for the year ended 30 September
2025, in terms of Regulation 43 of the Companies Regulations 2011, is available on the Company's website at
https://www.lifehealthcare.co.za/investor-relations/results-and-reports/

The remuneration report of the Company for the year ended 30 September 2025, in terms of the Companies Act,
Section 61, is available on the Company's website https://www.lifehealthcare.co.za/investor-relations/results-and-
reports/

Dunkeld
19 February 2026

Equity Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Debt Sponsor
Questco Corporate Advisory

Date: 19-02-2026 03:57:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.